JUANCARLOS BERMUDEZ: Open Payments
NPI 1770255697 · MONTROSE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 10 payments from 6 companies in 2025. Trend: 2023 $31 · 2024 $285 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Boston Scientific Corporation | 1 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $16 |
Products named: QULIPTA, REXULTI, Axonics, AIRSUPRA, Kerendia, BREZTRI, MOUNJARO.
Industry payments across CO — which companies pay providers there.
